TL;DR

• As of October 2026, GLP-1 medications in Singapore typically run S$250 to S$1,000 a month depending on the drug and dose. Ozempic sits at the low-mid end, Wegovy (officially available here since July 2025) at the high end.
• A basic ActiveSG pass runs S$30 a month. Even a premium gym membership tops out around S$200 to S$250.
• Pricing sources don't agree with each other. One clinical source puts Wegovy at S$500 to S$700, another at S$350 to S$1,000, and a 2025 NUS Medicine ethics review pegs real-world maintenance-dose cost at S$15,600 a year, roughly S$1,300 a month. That price fog is itself part of the story.
• On any reading, the jab is the pricier habit by a wide margin.
• More than half of self-pay users worldwide stop within a year, meaning many are paying full price for a treatment they don't finish, while a forgotten gym membership just quietly bleeds a smaller amount for longer.
• Doctors are also now telling GLP-1 users to keep training anyway, to protect the muscle mass the drug burns off alongside fat.
• The useful framing isn't "jab or gym." It's two recurring subscriptions competing for the same monthly budget: one with a steeper, murkier price and a documented dropout problem, one cheap, transparent, but frequently unused.

Singapore's obesity rate climbed from 10.5% in 2019-2020 to 12.7% in 2023-2024, with the sharpest rise among younger adults, according to the Ministry of Health's National Population Health Survey. Doctors here say they're fielding more enquiries about GLP-1 medications than ever. At the same time, gyms across the island continue running price wars, new boutique openings, and membership promotions to capture the same crowd chasing the same goal.

Both are being sold as the answer to the same problem. Both cost money every single month. Almost nobody is comparing them as what they actually are: two competing line items on a household budget.

The actual numbers, as of October 2026

First, a correction worth making up front: Wegovy is no longer unavailable in Singapore. The Health Sciences Authority approved it in February 2025, and it's been available by private prescription since July 2025, specifically registered for weight management. Ozempic, by contrast, remains a diabetes drug prescribed off-label for weight loss here.

Here's the problem anyone researching this hits almost immediately: no two sources quote the same price. A telehealth platform's own pricing guide puts Wegovy at S$500 to S$700 a month. A different cost breakdown from the same company elsewhere on its site quotes S$350 to S$1,000. A September 2025 ethics review published by NUS Medicine's Centre for Biomedical Ethics cites a real-world annual cost of S$15,600 at maintenance dose, about S$1,300 a month, nearly double the highest clinic quote. Ozempic is only slightly more consistent, with quotes ranging from S$250 to S$800 depending on dose and provider.

Treating the spread as the honest answer rather than picking one number:

None of this includes the initial consultation (S$50 to S$350, or bundled free on some telehealth platforms), baseline blood tests (S$80 to S$200), or follow-up visits (S$30 to S$150 each). Doses also typically escalate over the first several months, so month one is rarely what month six costs.

Gyms, by contrast, publish a rate card. Here's where things actually stand:

Even on the cheapest realistic GLP-1 route, low-dose Rybelsus at S$150 to S$250, the jab roughly matches a mid-tier gym. But the moment someone's on a standard therapeutic dose of Ozempic, Mounjaro, or especially Wegovy, they're paying anywhere from 2 to 3 times a premium gym membership to well over 40 times an ActiveSG pass. That gap holds even as global GLP-1 prices start falling: Novo Nordisk has announced cuts that will bring its US list price down toward roughly US$675 a month by January 2027, and oral versions are already cheaper to manufacture than injectables. The jab is getting cheaper. It is not, in the foreseeable future, getting cheaper than a gym pass, and right now, Singapore's own pricing is too inconsistent for anyone to budget against with confidence.

The subscription nobody finishes

Here's the number that should matter more to a budget-conscious reader than the sticker price: across international data, a slight majority of self-pay GLP-1 users, 53.6%, discontinue treatment within their first year. Cost and side effects are the two most commonly cited reasons.

That's not a minor detail. It means a meaningful share of people paying anywhere from S$250 to over S$1,000 a month are stopping before they've locked in the result they were paying for, and in many cases regaining the weight once they stop, since the drug only works while it's being taken. Financially, that's the same failure mode as an unused gym membership, money leaving the account for a habit that didn't stick, just at a much higher monthly rate and, often, a shorter runway before the person gives up.

A cancelled S$30 ActiveSG pass is a small, forgettable leak. A cancelled S$500-a-month Wegovy prescription, after eight or nine months of payments, is a four-figure sum spent on a result that didn't hold.

Why doctors are telling patients to keep the gym membership anyway

The more interesting wrinkle is that GLP-1s and exercise are increasingly being prescribed as a pair, not a substitute for one another. Clinical guidance is clear that all methods of significant weight loss, including GLP-1s, come with some loss of lean muscle mass alongside fat, and that pairing treatment with resistance training and adequate protein intake substantially preserves that muscle.

In other words, the medically sound version of this decision usually isn't "jab or gym." It's "jab and gym," which changes the maths considerably: a patient doing this properly in Singapore could realistically be paying S$250 to over S$1,000 for the prescription on top of a gym membership, not instead of one. That's the comparison most coverage of GLP-1s skips past, and it's the one that actually matters for anyone budgeting the decision rather than just Googling it.

Three questions worth asking before committing either way

1. What's the realistic monthly outlay for a full year, not month one?
   Doses on GLP-1s typically escalate, and gym add-ons (personal training, class packs) tend to creep. Price the twelfth month, not the first.
2. What's the actual completion rate you're planning around?
   With over half of self-pay GLP-1 users stopping within a year, and gym memberships famously under-used everywhere, the honest question isn't "which is more effective" but "which am I actually going to stick with long enough to justify the spend."
3. Is this a health decision or a budgeting decision dressed up as one?
   Both paths are legitimate. But the one that fits a household budget without quietly becoming the largest discretionary line item is the one worth choosing first, and it may well be neither the jab nor a premium gym, but the S$30 option that gets used consistently.

None of this is medical advice, and the right starting point for anyone considering a GLP-1 is a proper clinical consultation, not a cost spreadsheet. But the spreadsheet is still worth doing. Treated as a subscription decision rather than a health verdict, the honest comparison isn't "does it work," since both broadly do, for as long as they're actually used. It's which recurring cost a person will actually keep paying for long enough to see the result through.

FAQ

1. Is Wegovy available in Singapore?
   Yes. The Health Sciences Authority approved Wegovy in February 2025, and it's been available by private prescription since July 2025 for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. It isn't subsidised under any government scheme.

2. How much does Ozempic cost in Singapore?
   Typically S$250 to S$600 a month depending on dose, with some specialist clinics quoting up to S$800. Ozempic is approved in Singapore for type 2 diabetes; its use for weight loss is off-label and doctor-led.

3. How much does Wegovy cost in Singapore?
   Estimates vary widely, from S$500 to S$1,000 a month depending on provider and dose. A 2025 NUS Medicine ethics review estimated real-world maintenance-dose cost closer to S$1,300 a month, so it's worth getting a firm quote before committing rather than budgeting off any single published figure.

4. Is a GLP-1 cheaper than a gym membership in Singapore?
   No, not at a standard therapeutic dose. Even the cheapest gym option (ActiveSG at S$30 a month) costs a fraction of any GLP-1 medication, and even premium gyms at S$200 to S$250 a month are still cheaper than most GLP-1 routes once doses reach maintenance level.

5. Do doctors recommend stopping gym visits once on a GLP-1?
   No. Clinical guidance generally recommends continuing resistance training and maintaining adequate protein intake while on a GLP-1, since these medications cause some loss of muscle mass alongside fat loss.

6. What happens if someone stops taking a GLP-1?
   Weight regain is common. Slightly more than half of self-pay users worldwide discontinue treatment within a year, commonly due to cost or side effects, and weight loss benefits tend to reverse once the medication stops.

More From The Financial Coconut

Explore more money-and-life conversations at The Financial Coconut or catch the latest episodes on YouTube.

References

• Ministry of Health Singapore, National Population Health Survey 2024
• Biospectrum Asia, Novo Nordisk Makes Wegovy Available in Singapore for Weight Management
• NUS Medicine, Weighing up Ozempic
• Noah, Cost of Weight Loss Medication in Singapore (2026): Ozempic, Wegovy, Mounjaro Pricing
• Noah, Wegovy Singapore: Cost, Availability & How to Get a Prescription
• Regimen, Ozempic & Mounjaro in Singapore 2026: Cost, Access & How to Get It
• Rapidr, How Much Does GLP-1 Weight Loss Treatment Cost in Singapore?
• HealthDay, Novo Nordisk Cuts Prices of Ozempic and Wegovy Starting January 2027
• SingSaver, Cheapest Gyms in Singapore: Anytime Fitness, Virgin And More (2026)
• Fitness First Singapore, Gym Membership Price
• Axios, How Weight-Loss Drugs Are Reshaping Fitness Gyms

You can now be our community contributor and make a pitch to have your favourite personality be on our show.
Join our community group and drop us your insights on this topic.

 

Stay ahead in your financial journey! Sign up for our newsletter to receive insights, tips, and strategies from The Financial Coconut

Share:

Ozempic vs the Gym: What Are Singaporeans Actually Paying For?

Why Are DBS, OCBC and UOB Shares Falling? What Singapore Dividend Investors Should Know

Who Has Meta Poached So Far, and What Does It Mean for Singaporeans?

Digital Infrastructure Bill: What Singapore's New Data Centre Rules Mean for Your Banking Apps and REITs